EUVIMEDEUVIMED entdecken
Crossref

Apigenin ameliorates non-eosinophilic inflammation, dysregulated immune homeostasis and mitochondria-mediated airway epithelial cell apoptosis in chronic obese asthma via the ROS-ASK1-MAPK pathway

Hang Yu, Xi Huang, Hua-He Zhu, Na Wang, Cong Xie, Yao-Long Zhou, Han-Lin Shi, Meng-Meng Chen, Yue-Ren Wu, Zhen-Hui Ruan, Yu-Bao Lyu, Qing-Li Luo und 1 weitere

Phytomedicine · 2023-03 · 111 · 154646

DOI: 10.1016/j.phymed.2023.154646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2023-03. Verfasst von Hang Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institute of Integrative Medicine, Fudan University, Shangha…. Hauptthemen laut MEDLINE: Apigenin, Asthma. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Obese asthma is one of the important asthma phenotypes that have received wide attention in recent years. Excessive oxidative stress and different inflammatory endotypes may be important reasons for the complex symptoms, frequent aggravation, and resistance to traditional treatments of obese asthma. Apigenin (API), is a flavonoid natural small molecule compound with good anti-inflammatory and antioxidant activity in various diseases and proved to have the potential efficacy to combat obese asthma. METHODS: In vivo, this study fed C57BL/6 J mice with high-fat diets(HFD)for 12 weeks and then stimulated them with OVA for 6 weeks to establish a model of chronic obese asthma, while different doses of oral API or dexamethasone were used for therapeutic interventions. In vitro, this study used HDM to stimulate human bronchial cells (HBEs) to establish the model and intervened with API or Selonsertib (SEL). RESULTS: This study clarified that OVAinduced a type of mixed granulocytic asthma with elevated neutrophils and eosinophils in obese male mice fed with long-term HFD, which also exhibited mixed TH17/TH1/TH2 inflammation. Apigenin effectively suppressed this complex inflammation and acted as a regulator of immune homeostasis. Meanwhile, apigenin reduced AHR, inflammatory cell infiltration, airway epithelial cell apoptosis, airway collagen deposition, and lung oxidative stress via the ROS-ASK1-MAPK pathway in an obese asthma mouse model. In vitro, this study found that apigenin altered the binding status of TRAF6 to ASK1, inhibited ASK1 phosphorylation, and protected against ubiquitin-dependent degradation of ASK1, suggesting that ROS-activated ASK1 may be an important target for apigenin to exert anti-inflammatory and anti-apoptotic effects. To further verify the intervention mechanism, this study clarified that apigenin improved cell viability and mitochondrial function and inhibited apoptosis by interfering with the ROS-ASK1-MAPK pathway. CONCLUSIONS: This study demonstrates for the first time the therapeutic effect of apigenin in chronic obese asthma and further clarifies its potential therapeutic targets. In addition, this study clarifies the specificity of chronic obese asthma and provides new options for its treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApigeninAsthmaAnimalsHumansMaleMiceApoptosisEpithelial CellsHomeostasisInflammationLungMice, Inbred BALB CMice, Inbred C57BLMitochondriaObesityReactive Oxygen SpeciesMAP Kinase Kinase Kinase 5Mitogen-Activated Protein Kinases

Stichwörter der Autor:innen

ASK1ApigeninApoptosisChronic obese asthmaInflammationROS

Substanzen

ApigeninReactive Oxygen SpeciesMAP Kinase Kinase Kinase 5Mitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institute of Integrative Medicine, Fudan University, Shanghai, China.
  • Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institute of Integrative Medicine, Fudan University, Shanghai, China; Shanghai Key Laboratory of Bioactive Small Molecules, Fudan…
  • Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institute of Integrative Medicine, Fudan University, Shanghai, China. Electronic address: jcdong2004@126.com.

Zitieren

APA

Yu, H., Huang, X., Zhu, H. H., Wang, N., Xie, C., Zhou, Y. L., Shi, H. L., Chen, M. M., Wu, Y. R., Ruan, Z. H., Lyu, Y. B., Luo, Q. L., & Dong, J. C. (2023). Apigenin ameliorates non-eosinophilic inflammation, dysregulated immune homeostasis and mitochondria-mediated airway epithelial cell apoptosis in chronic obese asthma via the ROS-ASK1-MAPK pathway. Phytomedicine, 111, 154646. https://doi.org/10.1016/j.phymed.2023.154646

Vancouver

Yu H, Huang X, Zhu HH, Wang N, Xie C, Zhou YL, et al. Apigenin ameliorates non-eosinophilic inflammation, dysregulated immune homeostasis and mitochondria-mediated airway epithelial cell apoptosis in chronic obese asthma via the ROS-ASK1-MAPK pathway. Phytomedicine. 2023;111:154646. doi:10.1016/j.phymed.2023.154646

BibTeX
@article{Yu2023,
  author = {Yu, Hang and Huang, Xi and Zhu, Hua-He and Wang, Na and Xie, Cong and Zhou, Yao-Long and Shi, Han-Lin and Chen, Meng-Meng and Wu, Yue-Ren and Ruan, Zhen-Hui and Lyu, Yu-Bao and Luo, Qing-Li and Dong, Jing-Cheng},
  title = {Apigenin ameliorates non-eosinophilic inflammation, dysregulated immune homeostasis and mitochondria-mediated airway epithelial cell apoptosis in chronic obese asthma via the ROS-ASK1-MAPK pathway},
  journal = {Phytomedicine},
  year = {2023},
  volume = {111},
  pages = {154646},
  doi = {10.1016/j.phymed.2023.154646}
}
Kostenlos starten →